These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4869767)

  • 21. [Treatment of acute leukemias].
    Jacquillat C
    Cah Coll Med Hop Paris; 1968 May; 9(5):435-49. PubMed ID: 4886417
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience of use of bruneomycin in leukemia].
    Krasovskiĭ II; Kudinov VG
    Antibiotiki; 1969 Jan; 14(1):77-81. PubMed ID: 5253409
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome.
    Callera F; Lopes CO; Rosa ES; Mulin CC
    Leuk Res; 2008 Oct; 32(10):1633-4. PubMed ID: 18405970
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results obtained with the clinical use of adriamycin].
    Esposito S; Taylor LA
    Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
    Dano K; Nissen NI
    Nord Med; 1968 Oct; 80(44):1469-74. PubMed ID: 5247179
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of acute leukemias with L-asparaginase. Preliminary results].
    Jacquillat C; Weil M; Brunel-Kotschi R; Gemon MF; Levy D; Larrieu MJ; Bussel A; Tanzer J; Boiron M; Bernard J
    Med Welt; 1971 Mar; 13():503-8. PubMed ID: 5284282
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral complications in adult leukemic patients undergoing chemotherapy.
    Morry R; Lavelle CL
    Dent Hyg (Chic); 1984 Aug; 58(8):356-60. PubMed ID: 6590380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of rubomycin C on hemopoietic cells in vitro in various forms of acute leukemia].
    Gerasimova NA; Dul'tsina SM
    Probl Gematol Pereliv Krovi; 1970 Oct; 15(10):26-31. PubMed ID: 5285584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Abolition of delayed hypersensitivity reactions and the severity of aplasias induced by rubidomycin].
    Kourilsky FM; Dupuy JM; Fradelizi D; Jacquillat C; Bernard J
    Pathol Biol; 1967 Oct; 15(19):959. PubMed ID: 4869775
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
    Takemoto Y; Sampi K; Kuraishi Y; Toki H; Tamura K; Ogawa M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of bruneomycin in hematologic clinic].
    Petrov NS
    Antibiotiki; 1969 Jan; 14(1):81-6. PubMed ID: 5253410
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lü JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):750-2. PubMed ID: 16483490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].
    Qachouh M; Quessar A; Harif M; Benchekroun S
    Tunis Med; 2003 Jul; 81(7):461-5. PubMed ID: 14534956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acute myeloblastic leukemia by the combination of daunorubicin (or rubidazone) and cytosine arabinoside (apropos of 76 cases)].
    Bauters F; Jouet JP; Huart JJ; Jude B; Toussaint B; Goudemand M
    Lille Med; 1980 Dec; 25(10):559-68. PubMed ID: 6936592
    [No Abstract]   [Full Text] [Related]  

  • 37. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M
    Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
    Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
    Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cytological evolution of acute lymphoblastic leukemias treated with rubidomycin. (Preliminary note)].
    Lortholary P; Bonhomme J; Jacquillat C; Miélot F; Brière J; Boiron M; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):130-2. PubMed ID: 4226631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.